Euro-Med Laboratories Phil Inc 2022 SR
The report highlights Euro-Med Laboratories Phil., Inc.'s sustainability performance for the 2022 fiscal year, focusing on its role as a leading pharmaceutical manufacturer in the Philippines. The company achieved an 18% growth in direct economic value generated, totaling Php 3.17 billion. Key environmental initiatives included managing energy and water consumption, with a focus on using recycled low-density polyethylene for packaging. Socially, the company maintained a workforce of 1,088 employees and emphasized occupational health and safety, reporting zero work-related fatalities. The report aligns with GRI Standards and emphasizes contributions to UN SDG 3.
Company: Euro-Med Laboratories Phil Inc
Sector: Health Care
Country: Philippines
Year: 2022
Type: SR
Pages: 22
Euro-Med Laboratories Phil Inc
The report highlights Euro-Med Laboratories Phil., Inc.'s sustainability performance for the 2022 fiscal year, focusing on its role as a leading pharmaceutical manufacturer in the Philippines. The company achieved an 18% growth in direct economic value generated, totaling Php 3.17 billion. Key environmental initiatives included managing energy and water consumption, with a focus on using recycled low-density polyethylene for packaging. Socially, the company maintained a workforce of 1,088 employees and emphasized occupational health and safety, reporting zero work-related fatalities. The report aligns with GRI Standards and emphasizes contributions to UN SDG 3.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2022
Reporting Period
Jan 1, 2022 - Dec 31, 2022
Fiscal Year
2022
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Sustainable Development Goals
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Water Consumption
Total Waste
Workplace Fatalities
Employees